Post Covid-19 Olfactory dysfunction
Conditions
Interventions
1. Setting - ENT clinic of Colombo South Teaching Hospital of Sri lanka
2. Randomization
a. Method of randomization - Simple randomization 23 each for four groups
b. Unit of randomization - Patients
citronella, rose, cloves, and eucalyptus twice a day for three months
II. Nasal steroids: Two drops of Betamethasone (Probeta) 0.1% nasal drop twice daily for 3 months
III. Combination of both the ab
Sponsors
Colombo South Teaching Hospital
Eligibility
Inclusion criteria
Inclusion criteria: >18 years both males and females PCR confirmed COVID 19 patients Has anosmia or hyposmia as symptom following COVID 19 infection confirmed by Quick smell identification test Symptoms persisted for at least more than one month upto 3 months following confirmation of COVID 19
Exclusion criteria
Exclusion criteria: Previous nasal pathologies including sinonasal tumours, chronic rhinosinusitits, allergic rhinitis, pre-existing anosmia or hyposmia Patients with history of allergy to steroids and patients with past history of anaphylaxis Patients who are already on any kind of systemic or topical steroid Pregnant patients Patients with psychiatric disorders, intellectual disabilities and ambulatory disability Patients treated in ICU Clinical history and rhinological examination will be performed at the ENT clinic to exclude patients with other structural rhinological conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quick smell identification test (strip test to identify smell dysfunction which tests 3 different odours) 3 out of 3 score in the QSIT smell identification test [Prior to interventions and 3 months after interventions] | — |
Secondary
| Measure | Time frame |
|---|---|
| None [] | — |
Countries
Sri Lanka
Contacts
Public ContactDr. A S R De Alwis
Acting consultant in otorhinolaryngology
Outcome results
None listed